Latest Peervoice Podcast Episodes
Thomas Powles, MBBS, MRCP, MD - Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best Practices and Future Directions in Maintenance Therapy
PeerVoice Oncology & Haematology Video - May 10, 2024 23:00 - 16 minutes - Video ★★★★★ - 1 ratingThomas Powles, MBBS, MRCP, MD - Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best Practices and Future Directions in Maintenance Therapy
Christian Récher, MD, PhD - Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Optimising Our First-Line Approaches With Current and Novel Therapeutics
PeerVoice Oncology & Haematology Video - May 10, 2024 23:00 - 22 minutes - Video ★★★★★ - 1 ratingChristian Récher, MD, PhD - Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Optimising Our First-Line Approaches With Current and Novel Therapeutics
Sara Hurvitz, MD - A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer
PeerVoice Oncology & Haematology Video - May 10, 2024 23:00 - 26 minutes - Video ★★★★★ - 1 ratingSara Hurvitz, MD - A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer
Abdulazeez Salawu, MBBS, MSc, PhD - The Case for Biomarker-Guided Management of mCRC: Steps to Refine Care Along the Patient’s Journey
PeerVoice Oncology & Haematology Video - April 17, 2024 23:00 - 22 minutes - Video ★★★★★ - 1 ratingAbdulazeez Salawu, MBBS, MSc, PhD - The Case for Biomarker-Guided Management of mCRC: Steps to Refine Care Along the Patient’s Journey
Jeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
PeerVoice Oncology & Haematology Video - April 17, 2024 23:00 - 19 minutes - Video ★★★★★ - 1 ratingJeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
Jeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
PeerVoice Internal Medicine Audio - April 17, 2024 23:00 - 19 minutes ★★★★★ - 4 ratingsJeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
Jeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
PeerVoice Internal Medicine Video - April 17, 2024 23:00 - 19 minutes - VideoJeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
Jeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
PeerVoice Oncology & Haematology Audio - April 17, 2024 23:00 - 19 minutes ★★★★★ - 1 ratingJeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
Dirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
PeerVoice Oncology & Haematology Video - April 10, 2024 23:00 - 33 minutes - Video ★★★★★ - 1 ratingDirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
Dirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
PeerVoice Oncology & Haematology Audio - April 10, 2024 23:00 - 34 minutes ★★★★★ - 1 ratingDirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
Dirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
PeerVoice Internal Medicine Audio - April 10, 2024 23:00 - 34 minutes ★★★★★ - 4 ratingsDirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
Dirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
PeerVoice Internal Medicine Video - April 10, 2024 23:00 - 33 minutes - VideoDirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
Lisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
PeerVoice Internal Medicine Video - March 28, 2024 23:00 - 34 minutes - VideoLisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
Lisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
PeerVoice Oncology & Haematology Audio - March 28, 2024 23:00 - 35 minutes ★★★★★ - 1 ratingLisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
PeerVoice Internal Medicine Audio - March 28, 2024 23:00 - 33 minutes ★★★★★ - 4 ratingsFatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
PeerVoice Internal Medicine Video - March 28, 2024 23:00 - 33 minutes - VideoFatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
Lisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
PeerVoice Internal Medicine Audio - March 28, 2024 23:00 - 35 minutes ★★★★★ - 4 ratingsLisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
Lisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
PeerVoice Oncology & Haematology Video - March 28, 2024 23:00 - 34 minutes - Video ★★★★★ - 1 ratingLisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
PeerVoice Endocrinology & Metabolic Disorders Video - March 28, 2024 23:00 - 33 minutes - Video ★★★★★ - 1 ratingFatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
Lisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
PeerVoice Clinical Pharmacology Video - March 28, 2024 23:00 - 34 minutes - VideoLisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
PeerVoice Endocrinology & Metabolic Disorders Audio - March 28, 2024 23:00 - 33 minutes ★★★ - 6 ratingsFatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
PeerVoice Brain & Behaviour Audio - March 26, 2024 23:00 - 25 minutesAli Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
PeerVoice Internal Medicine Audio - March 26, 2024 23:00 - 25 minutes ★★★★★ - 4 ratingsAli Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
PeerVoice Internal Medicine Video - March 26, 2024 23:00 - 57 minutes - VideoJonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
PeerVoice Internal Medicine Audio - March 26, 2024 23:00 - 57 minutes ★★★★★ - 4 ratingsJonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
PeerVoice Clinical Pharmacology Audio - March 26, 2024 23:00 - 25 minutes ★★★★★ - 3 ratingsAli Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
PeerVoice Oncology & Haematology Audio - March 26, 2024 23:00 - 57 minutes ★★★★★ - 1 ratingJonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
PeerVoice Heart & Lung Video - March 26, 2024 23:00 - 57 minutes - VideoJonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
PeerVoice Internal Medicine Video - March 26, 2024 23:00 - 25 minutes - VideoAli Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
PeerVoice Oncology & Haematology Video - March 26, 2024 23:00 - 57 minutes - Video ★★★★★ - 1 ratingJonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Related Peervoice Topics
- Medical education 16
- 090993 16
- Dermatology 4
- Nephrology 4
- Oncology 2
- Haematology 2
- Hematology 2
- Cancer 2
- Endocrinology 2
- Diabetes 2
- Metabolic disorders 2
- Neurology 2
- Brain 2
- Psychiatry 2
- Neuroscience 2
- Pulmonology 2
- Cardiology 2
- Heart 2
- Lung 2
- Internal medicine 2
- Clinical pharmacology 2
- Immunology 2
- Infectious disease 2
- Rheumatology 2
- Gastroenterology 2
- Digestive diseases 2